Mini‐Review: Comprehensive Drug Disposition Knowledge Generated in the Modern Human Radiolabeled ADME Study
2020 · CPT Pharmacometrics & Systems Pharmacology · 60 citations
https://doi.org/10.1002/psp4.12540
D
Douglas K. Spracklin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
1.7K
Citations
18
h-index
22
i10-index
Douglas K. Spracklin is an academic researcher from Pfizer (United States). The author has contributed to research in topics: Pharmacogenetics and Drug Metabolism & Analytical Chemistry and Chromatography & Chemical Synthesis and Analysis. The author has an h-index of 18, co-authored 28 publications.
ORCID: 0000-0002-3471-1332Papers by this author
worksRecommendations on the Use of Multiple Labels in Human Mass Balance Studies
2024 · Drug Metabolism and Disposition · 6 citations
https://doi.org/10.1124/dmd.123.001429
Cross-industry demonstration of the validity of the mixed matrix method for the assessment of cross-species exposure coverage of human circulating drug metabolites
2025 · Drug Metabolism and Disposition · 0 citations
https://doi.org/10.1016/j.dmd.2025.100041
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat